drugset / Trial / NCT01472510
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to confirm that the investigational drug Ranibizumab given by injection into the eye is safe and effective to use in people with diabetic macular edema (DME).
Timeline
- Start
- 2011-12
- Primary completion
- 2013-07
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |